Skip to content
Home/Companies/Biotech/Northern Biologics

Northern Biologics

Biotech·Canada·Exited 2020·Held 4yr
Entry
2016
Hold
4yr
Exit
2020

Who owns Northern Biologics?

Northern Biologics was owned by Caixa Capital Risc through Criteria Bio Ventures (2002 vintage) from 2016 to 2020, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-03

Caixa Capital Risc
Investor
Caixa Capital Risc
Criteria Bio Ventures · 2002 · VC

Key facts

HQCanada
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2020

More from Criteria Bio Ventures

Other portfolio companies in the same fund.

Cytospire
Active
BiotechUnited Kingdom· 2026
Adaptam Therapeutics
Adaptam Therapeutics
Active
BiotechSpain· 2025
NRG Therapeutics
Active
BiotechUnited Kingdom· 2025
Tolerance Bio
Active
BiotechUnited States· 2024
Aboleris Pharma
Aboleris Pharma
Active
BiotechFrance· 2023
Minoryx Therapeutics
Minoryx Therapeutics
Active
BiotechSpain· 2015

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Northern Biologics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Northern Biologics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue